StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
95
This month
1
This year
15
Publishing Date
2024 - 02 - 22
2
2023 - 02 - 16
1
2023 - 02 - 09
1
2023 - 02 - 08
1
2022 - 12 - 08
1
2022 - 08 - 16
1
2022 - 07 - 26
1
2022 - 07 - 21
1
2022 - 06 - 30
1
2022 - 06 - 23
1
2022 - 06 - 10
1
2022 - 05 - 23
1
2022 - 05 - 09
1
2022 - 05 - 03
1
2022 - 05 - 02
1
2022 - 04 - 27
1
2022 - 03 - 23
1
2022 - 03 - 16
2
2022 - 03 - 01
1
2022 - 02 - 25
1
2022 - 02 - 17
1
2022 - 02 - 08
1
2022 - 01 - 18
1
2021 - 12 - 23
1
2021 - 12 - 08
1
2021 - 11 - 29
1
2021 - 10 - 29
1
2021 - 10 - 25
1
2021 - 10 - 13
1
2021 - 10 - 12
1
2021 - 09 - 24
1
2021 - 09 - 14
1
2021 - 09 - 01
1
2021 - 08 - 30
2
2021 - 08 - 16
1
2021 - 07 - 20
1
2021 - 06 - 25
1
2021 - 06 - 22
1
2021 - 06 - 21
1
2021 - 06 - 17
1
2021 - 06 - 14
1
2021 - 06 - 07
1
2021 - 05 - 28
1
2021 - 05 - 24
1
2021 - 05 - 07
1
2021 - 04 - 22
1
2021 - 04 - 16
1
2021 - 03 - 26
1
2021 - 03 - 25
1
2021 - 02 - 26
1
2021 - 02 - 22
1
2021 - 02 - 18
1
2021 - 02 - 03
1
2021 - 01 - 28
1
2021 - 01 - 26
1
2021 - 01 - 13
1
2021 - 01 - 05
1
2021 - 01 - 04
1
2020 - 12 - 31
1
2020 - 12 - 21
1
Sector
Commercial services
6
Consumer durables
1
Consumer services
1
Health services
12
Health technology
95
Manufacturing
6
Process industries
2
Producer manufacturing
3
Retail trade
1
Technology services
1
Tags
4kscore
1
Acquisition
1
Agreement
1
Alliances
3
Antibody
1
Application
3
Approval
1
Bio-nc
1
Biocanada
1
Biocapital
1
Biomidwest
1
Biotech
1
Bone
1
Business
1
Cancer
9
Candidate
1
Cardio
1
Cardiology
1
Care
1
China
3
Collaboration
5
Commercialization
2
Conference
2
Covid
7
Covid-19
4
Diagnostic
4
Diagnostics
3
Disease
6
Earnings
3
Ema
2
Events
3
Expansion
4
Fda
4
Financial
7
Financial results
6
Genetic
6
Genomic
3
Global
9
Group
2
Growth
11
Growth hormone
5
Health
30
Hormone
6
Kidney
2
License
3
Market
17
Million
2
N/a
73
Offering
4
Phase 2
2
Platform
2
Rare
3
Report
13
Research
8
Results
16
Test
15
Therapeutics
3
Treatment
4
Trial
3
Week
2
Entities
3m company
3
Abbott laboratories
7
Abbvie inc.
1
Abcam plc
2
Adaptive biotechnologies corporation
1
Advaxis, inc.
1
Agilent technologies, inc.
7
Alibaba group holding limited
1
Aptargroup, inc.
2
Arrival
1
Arrowhead pharmaceuticals, inc.
1
Astellas pharma inc
1
Astrazeneca plc
4
Astria therapeutics, inc.
1
Beam therapeutics inc.
2
Becton, dickinson and company
3
Bio-rad laboratories, inc.
3
Biohaven pharmaceutical holding company ltd.
2
Biontech se
2
Centogene n.v.
5
Cocrystal pharma, inc.
1
Danaher corporation
4
Eli lilly and company
1
Entera bio ltd.
3
Exact sciences corporation
3
Fulgent genetics, inc.
3
Glaxosmithkline plc
4
Horizon therapeutics public limited company
1
Icon plc
1
Illumina, inc.
9
Incyte corporation
1
Inhibrx, inc.
1
Invitae corporation
6
Ionis pharmaceuticals, inc.
2
Koninklijke philips n.v.
4
Krystal biotech, inc.
1
Laboratory corporation of america holdings
12
Myriad genetics, inc.
6
Natera, inc.
2
Nextplat corp
2
Novartis ag
4
Opko health, inc.
95
Orasure technologies, inc.
1
Perkinelmer, inc.
2
Pfizer, inc.
6
Progressive care inc.
1
Qiagen n.v.
4
Quest diagnostics incorporated
7
Quidel corporation
1
Renalytix ai plc
1
Royal caribbean group
1
Sab biotherapeutics inc
1
Sangamo therapeutics, inc.
2
Sanofi
4
Sony group corp
1
Standard biotools inc
1
Taysha gene therapies, inc.
1
Teva pharmaceutical industries ltd
2
Thermo fisher scientific inc
6
Veracyte, inc.
3
Symbols
AAPL
1198
ABB
1433
ABBV
1030
ABLZF
1172
ABT
1797
ACN
602
AMGN
744
ARVL
4319
AVGO
597
AZN
668
BDX
796
BMY
662
BNPQF
1768
BNPQY
1768
CSCO
900
DHR
786
ERIC
1617
F
643
FNCTF
7229
FRBA
602
GE
919
GLAXF
661
GOOG
1297
GOOGL
1296
GSK
887
HON
1793
HUBS
1400
IBM
657
INTC
955
IT
595
JNJ
4606
LLY
1711
LTUM
973
LYV
717
MDT
1286
MMM
938
MS
4298
MSFT
1205
MT
592
NOK
917
NOKBF
993
NVO
636
NVS
1245
NVSEF
1035
ORCL
1161
PCRFF
651
PCRFY
651
PFE
693
PHG
963
PPRUF
1131
PPRUY
1132
SAP
1481
SAPGF
1235
SNOW
796
SNY
4560
SNYNF
3618
TEVJF
633
TMO
1630
VZ
1223
XYF
678
Exchanges
Nasdaq
95
Nyse
33
Crawled Date
2024 - 02 - 22
2
2023 - 02 - 16
1
2023 - 02 - 09
1
2023 - 02 - 08
1
2022 - 12 - 08
1
2022 - 08 - 16
1
2022 - 07 - 26
1
2022 - 07 - 21
1
2022 - 06 - 30
1
2022 - 06 - 23
1
2022 - 06 - 10
1
2022 - 05 - 23
1
2022 - 05 - 09
1
2022 - 05 - 03
1
2022 - 05 - 02
1
2022 - 04 - 27
1
2022 - 03 - 23
1
2022 - 03 - 16
2
2022 - 03 - 01
1
2022 - 02 - 25
1
2022 - 02 - 17
1
2022 - 02 - 08
1
2022 - 01 - 18
1
2021 - 12 - 23
1
2021 - 12 - 08
1
2021 - 11 - 29
1
2021 - 10 - 29
1
2021 - 10 - 25
1
2021 - 10 - 13
1
2021 - 10 - 12
1
2021 - 09 - 24
1
2021 - 09 - 14
1
2021 - 09 - 01
1
2021 - 08 - 30
2
2021 - 08 - 16
1
2021 - 07 - 20
1
2021 - 06 - 25
1
2021 - 06 - 22
1
2021 - 06 - 21
1
2021 - 06 - 17
1
2021 - 06 - 14
1
2021 - 06 - 07
1
2021 - 05 - 28
1
2021 - 05 - 24
1
2021 - 05 - 07
1
2021 - 04 - 22
1
2021 - 04 - 16
1
2021 - 03 - 26
1
2021 - 03 - 25
1
2021 - 02 - 26
1
2021 - 02 - 22
1
2021 - 02 - 18
1
2021 - 02 - 03
1
2021 - 01 - 28
1
2021 - 01 - 26
1
2021 - 01 - 13
1
2021 - 01 - 05
1
2021 - 01 - 04
1
2020 - 12 - 31
1
2020 - 12 - 21
1
Crawled Time
01:00
1
02:00
1
05:00
1
09:00
2
10:00
2
11:00
4
12:00
14
12:15
2
12:20
1
12:30
4
13:00
6
13:03
3
13:15
2
14:00
9
14:03
1
14:07
1
14:15
2
14:30
1
15:00
1
15:15
1
15:30
1
16:00
3
17:00
4
18:00
3
19:00
6
20:00
6
21:00
8
21:07
1
22:00
4
Source
www.biospace.com
22
www.globenewswire.com
37
www.prnewswire.com
36
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
OPK
save search
Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research
Published:
2024-04-05
(Crawled : 11:00)
- prnewswire.com
LH
4
|
$207.94
-0.01%
0.0%
790K
|
Health Services
|
-4.13%
|
O:
-0.6%
H:
0.0%
C:
0.0%
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
-8.76%
|
O:
-0.73%
H:
0.74%
C:
-0.74%
labcorp
disease
research
molecular
Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
Published:
2024-03-20
(Crawled : 12:00)
- globenewswire.com
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
43.63%
|
O:
1.08%
H:
5.01%
C:
1.17%
ENTX
|
$2.07
-6.76%
-7.25%
160K
|
Health Technology
|
57.42%
|
O:
0.69%
H:
8.45%
C:
7.04%
treatment
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
Published:
2024-03-05
(Crawled : 14:00)
- globenewswire.com
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
25.0%
|
O:
-0.96%
H:
1.98%
C:
-5.6%
antibody
group
treatment
hiv
trial
results
study
NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st
Published:
2024-02-28
(Crawled : 14:30)
- prnewswire.com
NXPL
|
$1.29
9.32%
8.53%
140K
|
Manufacturing
|
-18.9%
|
O:
5.84%
H:
2.25%
C:
-5.19%
RXMD
|
$1.92
174.55%
2.4K
|
Retail Trade
|
-35.48%
|
O:
-13.98%
H:
16.67%
C:
16.67%
BABA
|
$74.63
2.92%
-1.27%
16M
|
Retail Trade
|
-6.66%
|
O:
-2.14%
H:
0.21%
C:
-1.88%
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
19.05%
|
O:
-4.76%
H:
1.0%
C:
-1.45%
global
china
platform
OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results
Published:
2024-02-27
(Crawled : 21:00)
- globenewswire.com
NXPL
|
$1.29
9.32%
8.53%
140K
|
Manufacturing
|
-18.9%
|
O:
5.84%
H:
2.25%
C:
-5.19%
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
19.05%
|
O:
-4.76%
H:
1.0%
C:
-1.45%
business
health
financial
results
OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024
Published:
2024-02-22
(Crawled : 21:00)
- globenewswire.com
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
28.85%
|
O:
2.74%
H:
0.33%
C:
-5.09%
report
health
financial
results
United States Clinical Laboratory Tests Markets, 2023 and 2024-2029: Intense Competition and Consolidation Likely to Continue, Advances and Integration of Technologies
Published:
2024-02-22
(Crawled : 17:00)
- prnewswire.com
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
23.76%
|
O:
0.99%
H:
1.96%
C:
-4.89%
integration
Multi-Billion Opportunities in the US Clinical Laboratory Tests Market, More than $109 Billion Revenue by 2029 - Arizton
Published:
2024-02-08
(Crawled : 18:00)
- prnewswire.com
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
25.0%
|
O:
-0.9%
H:
4.94%
C:
2.93%
revenue
SAB Biotherapeutics Announces Executive Leadership Change
Published:
2024-02-02
(Crawled : 12:30)
- globenewswire.com
SABS
|
$4.36
7.54%
730
|
|
-26.1%
|
O:
0.15%
H:
0.87%
C:
0.87%
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
23.76%
|
O:
-0.99%
H:
1.0%
C:
-0.5%
change
Carrier Screening Market Worth $5.4 Billion | MarketsandMarkets™
Published:
2024-01-31
(Crawled : 15:30)
- prnewswire.com
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
-0.3%
|
O:
-0.67%
H:
0.48%
C:
-4.32%
DGX
|
News
|
$137.55
0.62%
0.0%
1.6M
|
Health Services
|
6.11%
|
O:
0.46%
H:
0.41%
C:
-0.76%
LH
4
|
$207.94
-0.01%
0.0%
790K
|
Health Services
|
-9.86%
|
O:
0.53%
H:
0.0%
C:
-2.31%
NVTA
|
News
|
$0.019
0.0%
22M
|
Health Services
|
-95.32%
|
O:
-0.2%
H:
2.4%
C:
-3.7%
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
23.76%
|
O:
0.0%
H:
4.95%
C:
0.99%
NTRA
|
News
M
|
$91.47
0.47%
0.47%
810K
|
Health Services
|
37.94%
|
O:
-0.76%
H:
2.2%
C:
0.67%
ILMN
|
$122.74
-1.38%
-1.4%
1.2M
|
Health Technology
|
-15.45%
|
O:
-0.49%
H:
1.17%
C:
-2.37%
CNTG
|
$0.475
-1.04%
-1.05%
19K
|
Commercial Services
|
-58.62%
|
O:
-0.86%
H:
0.0%
C:
-0.43%
market
Global Microfluidic Devices Market to Surge to US$ 45.18 Billion by 2030 with Technological Advancements Driving Growth
Published:
2024-01-25
(Crawled : 02:00)
- prnewswire.com
LAB
|
$2.42
-5.47%
-5.79%
2.3M
|
Manufacturing
|
9.4%
|
O:
-0.43%
H:
1.72%
C:
1.29%
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
3.01%
|
O:
-1.03%
H:
0.84%
C:
-0.92%
PHG
|
News
|
$20.97
-0.19%
0.0%
650K
|
Health Technology
|
-8.01%
|
O:
0.0%
H:
0.57%
C:
0.48%
DHR
|
$250.41
-1.07%
-0.72%
3.3M
|
Health Technology
|
10.72%
|
O:
1.19%
H:
0.34%
C:
-1.7%
BDX
|
$233.83
-0.23%
3.49%
780K
|
Health Technology
|
-0.09%
|
O:
0.48%
H:
0.45%
C:
0.37%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
-2.98%
|
O:
0.47%
H:
1.04%
C:
0.93%
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
25.13%
|
O:
1.1%
H:
0.0%
C:
-2.26%
ILMN
|
$122.74
-1.38%
-1.4%
1.2M
|
Health Technology
|
-11.74%
|
O:
1.9%
H:
0.79%
C:
-0.65%
global
growth
market
OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes
Published:
2024-01-09
(Crawled : 21:00)
- globenewswire.com
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
20.19%
|
O:
1.92%
H:
2.83%
C:
-4.72%
health
million
offering
OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published:
2024-01-08
(Crawled : 13:00)
- globenewswire.com
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
40.67%
|
O:
4.66%
H:
10.75%
C:
7.53%
conference
health
OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029
Published:
2024-01-05
(Crawled : 05:00)
- globenewswire.com
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
37.86%
|
O:
0.99%
H:
3.61%
C:
-2.96%
health
million
offering
OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029
Published:
2024-01-03
(Crawled : 22:00)
- globenewswire.com
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
-16.67%
|
O:
-18.67%
H:
0.0%
C:
-25.68%
health
offering
In-Depth Market Analysis of Rare Genetic Disorders: Familial Chylomicronemia Syndrome (FCS), Netherton Syndrome, and Acromegaly | Key Insights by DelveInsight
Published:
2023-12-18
(Crawled : 22:00)
- prnewswire.com
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-2.87%
|
O:
0.45%
H:
0.0%
C:
0.0%
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
-18.83%
|
O:
0.65%
H:
4.52%
C:
4.52%
ARWR
|
$23.285
-2.08%
-2.13%
810K
|
Health Technology
|
-14.89%
|
O:
1.57%
H:
6.03%
C:
5.71%
rare
genetic
market
Entera Bio Reports Q3 2023 Financial Results, Highlights Transformational Steps and Unveils Vision as Premier Oral Peptide Company with Five Potential Programs in Development
Published:
2023-11-14
(Crawled : 12:30)
- globenewswire.com
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
-2.34%
|
O:
2.34%
H:
6.87%
C:
6.11%
ENTX
|
$2.07
-6.76%
-7.25%
160K
|
Health Technology
|
217.14%
|
O:
0.0%
H:
3.0%
C:
2.86%
company
financial
potential
Navigating the Complex Market Landscape of Rare Genetic Disorders: A Deep Dive into Hereditary Angioedema, Wilson Disease, Menkes Disease, and Alpha-1 Antitrypsin Deficiency (AATD) | DelveInsight
Published:
2023-11-09
(Crawled : 22:00)
- prnewswire.com
ATXS
|
$9.02
-6.43%
-6.87%
660K
|
Manufacturing
|
107.76%
|
O:
0.43%
H:
0.86%
C:
-1.29%
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
-2.34%
|
O:
1.56%
H:
0.0%
C:
-3.08%
IONS
|
$42.455
1.47%
1.45%
730K
|
Health Technology
|
-11.56%
|
O:
0.53%
H:
0.38%
C:
-2.52%
INBX
|
$34.385
0.75%
0.74%
220K
|
Health Technology
|
86.5%
|
O:
0.98%
H:
5.52%
C:
3.35%
INCY
|
$51.72
0.14%
0.14%
1.5M
|
Health Technology
|
-1.66%
|
O:
0.4%
H:
0.0%
C:
-0.55%
rare
genetic
market
New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023
Published:
2023-11-02
(Crawled : 14:00)
- globenewswire.com
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
0.0%
|
O:
1.6%
H:
2.36%
C:
0.79%
rayaldee
kidney
week
OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023
Published:
2023-10-31
(Crawled : 12:00)
- globenewswire.com
OPK
|
$1.225
-2.0%
-2.04%
6.1M
|
Health Technology
|
1.63%
|
O:
-0.81%
H:
3.28%
C:
2.46%
report
health
financial
results
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.